Reducing prescription drug costs for seniors: The ABCs of ASP for Part D
As we move into 2021, it is time to take stock of the myriad proposals related to making prescription drugs more affordable for patients. Both political...
Mr. Matthew Majewski has a track record of providing life science clients with analytically based solutions to their strategic issues.
He has led a range of strategy engagements from product related topics to corporate challenges. Prior to joining CRA, Mr. Majewski was a consultant at Stratēgyx where he developed managed market strategies for pre-launch products and designed managed market organizations.